Woloschuk D M, Wermeling J R, Pruemer J M
Oncology/Bone Marrow Transplant, Health Sciences Centre, Winnipeg, Manitoba, Canada.
Am J Hosp Pharm. 1991 Oct;48(10):2158-60.
The stability and compatibility of fluorouracil admixtures with mannitol during simulated Y-site administration was studied. Fluorouracil injection 50 mg/mL was diluted with 5% dextrose injection, 0.9% sodium chloride injection, and 5% dextrose and 0.45% sodium chloride injection to final concentrations of 1 and 2 mg/mL. Combinations of fluorouracil admixtures with 20% mannitol injection were made using equal volumes in glass test tubes; immediately after mixing and at one, two, and four hours, the samples were examined for visual incompatibilities. Duplicate combinations of fluorouracil admixtures with 20% mannitol injection were made using equal volumes in plastic syringes; immediately after mixing with internal standard in glass test tubes and at 2, 4, 8, and 24 hours, samples were removed for chemical analysis. A high-performance liquid chromatographic assay was used to determine fluorouracil concentrations. No evidence of precipitation, color change, or haze was observed. During the 24-hour study, fluorouracil concentrations remained within 6% of initial concentrations for all combinations with mannitol. Fluorouracil 1 and 2 mg/mL in 5% dextrose injection, 0.9% sodium chloride injection, and 5% dextrose and 0.45% sodium chloride injection was chemically stable and visually compatible when combined with 20% mannitol injection during simulated Y-site administration.
研究了氟尿嘧啶混合物与甘露醇在模拟Y型给药过程中的稳定性和相容性。将50mg/mL的氟尿嘧啶注射液用5%葡萄糖注射液、0.9%氯化钠注射液以及5%葡萄糖和0.45%氯化钠注射液稀释至最终浓度为1mg/mL和2mg/mL。在玻璃试管中使用等体积的氟尿嘧啶混合物与20%甘露醇注射液进行混合;混合后立即以及在1小时、2小时和4小时时,检查样品是否存在肉眼可见的不相容性。在塑料注射器中使用等体积的氟尿嘧啶混合物与20%甘露醇注射液进行重复混合;在与玻璃试管中的内标混合后立即以及在2小时、4小时、8小时和24小时时,取出样品进行化学分析。采用高效液相色谱法测定氟尿嘧啶浓度。未观察到沉淀、颜色变化或浑浊现象。在为期24小时的研究中,与甘露醇的所有组合中,氟尿嘧啶浓度均保持在初始浓度的6%以内。在模拟Y型给药过程中,当5%葡萄糖注射液、0.9%氯化钠注射液以及5%葡萄糖和0.45%氯化钠注射液中的氟尿嘧啶浓度为1mg/mL和2mg/mL时,与20%甘露醇注射液混合后化学性质稳定且肉眼可见相容。